ABUSArbutus Biopharma Corp
ABUS holders
Who holds Arbutus Biopharma Corp, from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
- Managers
- 215
- Shares held
- 132.6M
- Value held
- $629M
- Opened
- 64
- Closed
- 20
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| SJS Investment Consulting Inc. | 167 | New | $799 | 0.1% | Oct 26, 2026 |
| Farther Finance Advisors, LLC | 136 | New | $650 | 0% | Oct 8, 2026 |
| Price T Rowe Associates Inc | 133.8K | ±0% | $640 | 0.1% | Nov 16, 2026 |
| Rothschild Investment LLC | 130 | New | $621 | 0% | Nov 10, 2026 |
| Rialto Wealth Management, LLC | 116 | ±0% | $555 | 0.1% | Nov 16, 2026 |
| Federation des caisses Desjardins du Quebec | 100 | ±0% | $478 | 0% | Nov 16, 2026 |
| Harbour Investments, Inc. | 50 | New | $239 | 0% | Nov 9, 2026 |
| Clearstead Advisors, LLC | 25 | ±0% | $120 | 0% | Nov 6, 2026 |
| Assetmark, Inc | 17 | New | $81 | 0% | Oct 21, 2026 |
| DekaBank Deutsche Girozentrale | 12.5K | New | $61 | 0.1% | Oct 27, 2026 |
| Harbor Capital Advisors, Inc. | 12.8K | New | $61 | 0.1% | Oct 22, 2026 |
| StoneRidge PMG Advisors, LLC | 10.1K | — | $48 | 0.1% | Nov 4, 2026 |
| State of Alaska, Department of Revenue | 10K | New | $47 | 0.1% | Oct 15, 2026 |
| Avion Wealth | 1.5K | ±0% | $7 | 0.1% | Nov 4, 2026 |
| Hantz Financial Services, Inc. | 171 | ±0% | $1 | 0% | Nov 9, 2026 |